AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis – AstraZeneca Commentaries: AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says – CNN AND AstraZeneca’s Covid-19 vaccine shows better-than-expected efficacy in U.S. trial – STAT AND Expert reaction to press release from AstraZeneca announcing interim data on safety […]

The post [Press release – not published yet] AstraZeneca vaccine 79% effective for preventing symptomatic COVID-19 appeared first on Links Medicus.